How Cardiologists’ High Hopes for Two Drugs Were Dashed

The Quick Take
By every measure, the drugs were no better than placebos, full data revealed on Saturday. Was it the fault of the design of the studies, or our very hypotheses about heart disease?
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to NYT Business.
Related
Business
Off-Broadway Production DUST Raises $30,000 for Young Adults with Autism
LOS ANGELES, Nov. 7, 2026 /PRNewswire/ -- The Off-Broadway production DUST raised $30,000 to support young adults with autism in partnership with Cultural…
Business
Clough Global Opportunities Fund director buys $1,996 in GLO shares
Business
How #Amazon's low prices raises #prices. #soexpensive
------------------------------------------------------ Business Insider is a global newsroom covering business, technology, innovation, and the economy. Visit…
Business
